Initial investigations have shown that anti-diabetic drugs can counteract obesity-upregulated Lcn2 expression and circulating abundance in rats, T2D mice, and humans with T2D [200, 206]. The gene discussed is LCN2; the disease is obesity due to melanocortin 4 receptor deficiency.